Dechra Pharmaceuticals PLC Admission of Placing Shares & Total Voting Rights (3067D)
30 January 2018 - 7:15PM
UK Regulatory
TIDMDPH
RNS Number : 3067D
Dechra Pharmaceuticals PLC
30 January 2018
30 January 2018
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
LEI: 213800J4UVB5OWG8VX82
Admission of Placing Shares and Total Voting Rights
Further to the announcement of the result of the Company's
placing on 25 January 2018, the following information is released
in accordance with DTR 5.6.1A:
As at the date of this announcement, following the Admission of
the Placing Shares, the Company's issued share capital consists of
98,613,622 ordinary shares with a nominal value of 1 pence each
(Ordinary Shares), with voting rights. The Company does not hold
any Ordinary Shares in Treasury.
Therefore, the total number of Ordinary Shares with voting
rights is 98,613,622.
The above figure of 98,613,622 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change in their interest in, the share capital of
the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
Dechra Pharmaceuticals PLC
Telephone number: +44 (00 1606 814730
Email: corporate.enquiries@dechra.com
About Dechra
Dechra is an international specialist veterinary pharmaceuticals
and related products business. Our expertise is in the development,
manufacture, and sales and marketing of high quality products
exclusively for veterinarians worldwide. The majority of Dechra's
products are focused on key therapeutic categories where we have
leading market positions, and many of our products are used to
treat medical conditions for which there is no other effective
solution or have a clinical or dosing advantage over competitor
products. For more information, please visit: www.dechra.com.
Trademarks
Trademarks appear throughout this document in italics. Dechra
and the Dechra "D" logo are registered trademarks of Dechra
Pharmaceuticals PLC.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCVBLBXVFFFBBF
(END) Dow Jones Newswires
January 30, 2018 03:15 ET (08:15 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From Apr 2024 to May 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
From May 2023 to May 2024